November 11, 2020 Subject: Management’s Discussion and Analysis for the third quarter of 2020 To: The President The Stock Exchange of Thailand (SET) DOD Biotech Public Company Limited and its subsidiaries

Page 1 of 4 No. RJH – SET 14/2017 10 November 2017 Subject : Management Discussion and Analysis for the 3rd Quarter of 2017 ending 30 September 2017 To : The President The Stock Exchange of Thailand

baht, increased 2.8 million baht or 0.3 percent compared to non-current assets as of December 31, 2018. The significant change was mainly from the increase in investment property 7.2 million baht and

(Ending March 31, 2020) To Director and Manager of the Stock Exchange of Thailand Ubis (Asia) Public Company Limited (“the Company”) would like to clarify on the performance and the financial status for the

Exchange of Thailand CAZ (Thailand) Public Company Limited (“the Company”) and its Subsidiary (“the Group”) would like to clarify the change in operating result for the 1stQuarter ended 31 March 2020, which

remaining amount of GLOW’s shares of 69,530,219 shares, or 4.75% of the total shares, at Baht 90.8136 per share. The company may be able to adjust the price if GLOW (1) Offer dividend paymen t (2) Change in

. OCMSET/1907/003 July 30, 2019 Subject: Clarification of the operating results for the six-month period of 2019, change of rate more than 20% Dear: Director and Manager the Stock Exchange of Thailand

in a complete stoppage of the plant. Using this opportunity, the Company preponed its Annual Maintenance Shutdown, which was earlier planned for May, 2019, by working strategically to align all

: The President The Stock Exchange of Thailand Takuni Group Public Company Limited (“The Company”) and its subsidiaries (“The Group”) would like to clarify the change in operating result for the period

persons); therefore, it no longer has control in the company, resulting in the change of MACO’s status from a subsidiary to an associate company of VGI.  After the restructuring, MACO will focus on